Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Effects of Programming Parameters on Back Pain Relief in Subthreshold Spinal Cord Stimulation

Not Applicable

Terminated

Conditions: Low Back Pain

Interventions: Device: Boston Scientific Precision Plus spinal cord stimulation therapy

First Posted Date: 2012-03-12

Last Posted Date: 2021-04-29

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1

Registration Number: NCT01550562

Locations: 🇦🇺
Hunter Pain Clinic, Newcastle, New South Wales, Australia

WallFlex Biliary Fully Covered (FC) Chronic Pancreatitis Study

Not Applicable

Completed

Conditions: Biliary Stricture

Interventions: Device: Commercially available Plastic Stent Per Investigator preference
Device: WallFlex™ Biliary RX Fully Covered Stent System RMV

First Posted Date: 2012-03-02

Last Posted Date: 2023-01-09

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 172

Registration Number: NCT01543256

Locations: 🇦🇺
Royal Prince Alfred Medical Center, Newtown, New South Wales, Australia
🇦🇺
Westmead Hospital, Westmead, New South Wales, Australia
🇦🇹
Allgemeines Krankenhaus AKH, Vienna, Austria

and more 11 locations

Treatment of Resistant Hypertension Using a Radiofrequency Percutaneous Transluminal Angioplasty Catheter

Not Applicable

Completed

Conditions: Hypertension

Interventions: Device: Renal Denervation

First Posted Date: 2012-03-01

Last Posted Date: 2015-11-25

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 146

Registration Number: NCT01541865

Locations: 🇦🇺
St. Vincent's Hospital, Sydney, New South Wales, Australia
🇦🇺
The Prince Charles Hospital, Cardiology Clinical Research Centre, Brisbane, Queensland, Australia
🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia

and more 23 locations

ELEVATE (Evaluation of Left Ventricular Autothreshold) 3.0

Completed

Conditions: Heart Failure

Interventions: Device: Cardiac pacing

First Posted Date: 2012-02-27

Last Posted Date: 2012-12-05

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 50

Registration Number: NCT01539629

Locations: 🇺🇸
Genesis Medical Center, Davenport, Iowa, United States
🇺🇸
Cardiology Consultants of Philadelphia, Yardley, Pennsylvania, United States
🇺🇸
Virginia Commonwealth University Health System, Richmond, Virginia, United States

and more 1 locations

SpaceOAR System Pivotal Study

Phase 3

Completed

Conditions: Prostate Cancer

Interventions: Device: SpaceOAR System

First Posted Date: 2012-02-24

Last Posted Date: 2021-03-19

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 222

Registration Number: NCT01538628

Locations: 🇺🇸
Foundation for Cancer Research and Education, Phoenix, Arizona, United States
🇺🇸
Urological Surgeons of Northern California, Campbell, California, United States
🇺🇸
Radiological Associates of Sacramento, Sacramento, California, United States

and more 16 locations

Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy

Phase 3

Completed

Conditions: Sub-massive Pulmonary Embolism
Massive Pulmonary Embolism
Pulmonary Thromboembolism
Pulmonary Embolism
Acute Pulmonary Embolism

Interventions: Drug: recombinant tissue plasminogen activator
Device: EKOS EkoSonic Endovascular System

First Posted Date: 2012-01-20

Last Posted Date: 2021-07-19

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 150

Registration Number: NCT01513759

Locations: 🇺🇸
Baptist Health, Montgomery, Alabama, United States
🇺🇸
Memorial Medical Center, Modesto, California, United States
🇺🇸
Stanford University Medical Center, Stanford, California, United States

and more 19 locations

PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)

Phase 3

Completed

Conditions: Coronary Artery Disease

Interventions: Device: PROMUS Element Everolimus-Eluting Coronary Stent System
Drug: Aspirin
Drug: Thienopyridine

First Posted Date: 2012-01-16

Last Posted Date: 2019-03-26

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 22

Registration Number: NCT01510327

Locations: 🇺🇸
Medical Center of the Rockies (Loveland), Loveland, Colorado, United States
🇺🇸
Cardiac & Vascular Research Center of Northern Michigan, Petoskey, Michigan, United States
🇯🇵
Saiseikai Yokohama-City Eastern Hospital, Yokohama City, Kanagawa-ken, Japan

and more 2 locations

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)

Phase 3

Completed

Conditions: Coronary Artery Disease

Interventions: Device: PROMUS Element Coronary Stent System
Drug: Aspirin
Drug: Thienopyridine

First Posted Date: 2011-12-28

Last Posted Date: 2019-03-26

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 102

Registration Number: NCT01500434

Locations: 🇺🇸
Scripps Clinic, La Jolla, California, United States
🇺🇸
Mercy General Hospital, Sacramento, California, United States
🇺🇸
Alvarado Hospital, San Diego, California, United States

and more 27 locations

Boston Scientific OffRoad™ Re-entry Catheter System for Subintimal Recanalization of Chronic Total Occlusions in Femoropopliteal Arteries

Phase 4

Completed

Conditions: Chronic Total Occlusion

Interventions: Device: OffRoad Re-entry Catheter System

First Posted Date: 2011-12-26

Last Posted Date: 2014-04-15

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 92

Registration Number: NCT01500031

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels

Not Applicable

Completed

Conditions: Coronary Artery Disease

Interventions: Device: PROMUS Element Coronary Stent System

First Posted Date: 2011-12-23

Last Posted Date: 2019-03-26

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 94

Registration Number: NCT01498692

Locations: 🇺🇸
Bakersfield Memorial Hospital, Bakersfield, California, United States
🇺🇸
Mediquest Research at Munroe Regional Medical Center, Ocala, Florida, United States
🇺🇸
Florida Hospital, Orlando, Florida, United States

and more 20 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy